Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EuRbG2018 for relapsed retinoblastoma
NCT04455139Phase 2Terminated
- Start
- Nov 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in retinoblastoma (Rb). Started Nov 2021; status: terminated.
02
Drugs
topotecan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT04455139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04455139.